In combination with early‐life adversity, demethylation of FKBP5 has been reported (Hohne et al., 2014; Klengel et al., 2013), which could lead to a higher expression of FKBP5 rendering the affected individual more prone to glucocorticoid resistance and psychiatric disorders (Binder et al., 2008; Zimmermann et al., 2011). The gene discussed is FKBP5; the disease is psychiatric disorder.